Screener
Vertex Pharmaceuticals VRTX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's book value per share?
- Vertex Pharmaceuticals (VRTX) reported book value per share of $79.34 in Q2 2026.
- How has Vertex Pharmaceuticals's book value per share changed year-over-year?
- Vertex Pharmaceuticals's book value per share increased by 19.6% year-over-year, from $66.34 to $79.34.
- What is the long-term trend for Vertex Pharmaceuticals's book value per share?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's book value per share has grown at a 17.0% compound annual growth rate (CAGR), from $33.02 to $72.35.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Vertex Pharmaceuticals's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude